Benzinga | Aug 6, 2021 07:51AM EDT

Barclays Maintains Overweight on Cardinal Health, Lowers Price Target to $68

Barclays analyst Steve Valiquette maintains Cardinal Health (NYSE:CAH) with a Overweight and lowers the price target from $71 to $68.